Scientists squeeze and release heart failure patients to uncover exercise secrets
NCT ID NCT05764564
First seen Jun 25, 2026 · Last updated Sep 11, 2026 · Updated 2 times
Summary
This study looked at how applying positive or negative pressure around the body affects exercise in people with heart failure with preserved ejection fraction. 27 participants, including healthy volunteers and heart failure patients, were tested non-invasively and some invasively. The goal was to measure changes in cardiac output, heart rate, and other factors during exercise.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors understand how body pressure changes affect exercise capacity in heart failure patients, potentially guiding future treatments.
- What could go wrong
- This is a small, early-phase study (27 participants) focused on understanding mechanisms, not testing a treatment. Results may not apply to all heart failure patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
27 people
The number who actually took part.
- Started
-
Apr 2023
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* Heart Failure Study Population * Inclusion Criteria (Aim 1 and 2): * Age greater than or equal to 30 yrs * Established diagnosis of HFpEF with left ventricular ejection fraction greater than or equal to 50% * NYHA II-III symptoms * Stable HF drug regimen for the preceding 1 month * Wedge pressure greater than or equal to 15 mmHg at rest or greater than or equal to 25 mmHg with peak exercise * (For Aim 2 only) Scheduled for an elective right heart catheterization at Duke University Hospital. * Exclusion Criteria (Aim 1 and 2): * HF hospitalization for type I myocardial infarction within 3 months * Infiltrative (ie amyloid) or hypertrophic cardiomyopathy * Uncontrolled atrial or ventricular arrhythmia * Chronic oxygen use * History of vasovagal syncope * Considered inappropriate to participate by PI or Sub-I * Healthy Volunteers (Controls) * Inclusion Criteria (Aim 1): * Age greater than or equal to 30 yrs * Able to speak English * Ambulatory \[assistive devices ok\] * Able to provide informed consent * Exclusion Criteria (Aim 1): * Acute myocardial infarction (3-5 days) * Unstable angina * Uncontrolled arrhythmia causing symptoms or haemodynamic compromise * Syncope * Active endocarditis * Acute myocarditis or pericarditis * Symptomatic severe aortic aneurysm * Uncontrolled asthma * Arterial desaturation at rest on room air \<85% * Untreated left main stem coronary stenosis * Asymptomatic severe aortic stenosis * Severe untreated arterial hypertension at rest (\>200 mm Hg systolic, \>120 mm Hg diastolic) * Tachyarrhythmias or bradyarrhythmias * Hypertrophic cardiomyopathy * Significant pulmonary hypertension * Thrombosis of the lower extremity until treated for a minimum of 2 weeks * Within 2 weeks of acute symptomatic pulmonary embolus * Abdominal aortic aneurysm \>8.0 cm * Electrolyte abnormalities * Pregnancy * Inmate of correctional facility (i.e. prisoner) * Diagnosed history of dementia * Inability to ambulate independently * Considered inappropriate to participate by Principal Investigator
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure, diastolic are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple heart scan may unmask a hidden cause of heart failure
- Can a single gene infusion rebuild failing hearts?
- Can special exercise programs help heart failure patients breathe easier?
- Gut health breakthrough? probiotic shows promise for heart failure
- Could mounjaro ease heart failure in obesity? new trial investigates
- New heart failure drug enters first human safety trial